Andrew Philip Witty is the Chief Executive Officer of GlaxoSmithKline (GSK). Witty succeeded previous CEO Dr. Jean-Pierre Garnier following his retirement in May 2008. He is paid an annual salary of £687,000 and an annual bonus of £999,000 for this role.

PropertyValue
dbpprop:abstract
  • Andrew Philip Witty is the Chief Executive Officer of GlaxoSmithKline (GSK). Witty succeeded previous CEO Dr. Jean-Pierre Garnier following his retirement in May 2008. He is paid an annual salary of £687,000 and an annual bonus of £999,000 for this role.
dbpprop:hasPhotoCollection
dbpprop:reference
rdf:type
rdfs:comment
  • Andrew Philip Witty is the Chief Executive Officer of GlaxoSmithKline (GSK). Witty succeeded previous CEO Dr. Jean-Pierre Garnier following his retirement in May 2008. He is paid an annual salary of £687,000 and an annual bonus of £999,000 for this role.
rdfs:label
  • Andrew Witty
owl:sameAs
skos:subject
foaf:page
is dbpedia-owl:Organisation/keyPerson of
is dbpedia-owl:keyPerson of
is dbpprop:keyPeople of
is owl:sameAs of